CSI Market
Sign In | Register

Indaptus Therapeutics Inc (INDP) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INDP quarterly Cash Flow →
Looking at cash flow data from Indaptus Therapeutics Inc through Dec 31 2021 provides insight into Dec 31 2025's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-20.85
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.36
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Exchange Differences On Cash And Cash Equivalents And Restricted Cash-
Change In Operating Right Of Use Asset-
Change In Operating Lease Liabilities-
Debt Securities Available For Sale Realized Gain-
Warrant Repricing1.15
Increase Decrease In Operating Lease Right Of Use Asset And Liability Net-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Notes Payable, Current0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.67
Other Working Capital2.85
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-14.82
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale, Maturity and Collection of Short-term Investments0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net5.71
Other borrowing transactions-0.57
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock6.40
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock6.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.79
Proceeds From Issuance Of Ordinary Shares And Warrants Net Of Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations5.79
Interest Received-
Proceeds From Issuance Of Ordinary Shares And Warrants Net Of Issuance Costs-
Proceeds From Issuance Of Additional Ordinary Shares And Warrants Net Of Issuance Costs-
Proceeds From Issuance Of Ordinary Shares Net Of Issuance Costs Related To Affiliates-
Proceeds From Merger-
Proceeds From Issuance of Pre Funded Warrants and Warrants-
Proceeds From Simple Agreements for Futrue Equity-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities17.54
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-14.82
Total Cash Flow2.72
4 historic quarters locked

Sign in to unlock the full Indaptus Therapeutics Inc cash flow history.

Sign In Create Free Account

About Indaptus Therapeutics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 17, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-010585

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License